全球非甾體抗炎藥市場規模調查:按適應症、給藥途徑、分銷渠道和地區預測（2022-2028 年）

預計在 2022-2028 年的預測期內，全球非甾體抗炎藥市場將保持健康的增長速度。

由於全球慢性疼痛患病率不斷增加和全球人口老齡化等因素，非甾體抗炎藥 (NSAID) 市場正在擴大。此外，關節炎和其他與疼痛相關的疾病的患病率上升預計將推動整個預測期內的市場擴張。然而，藥物副作用預計將阻礙整個預測期內的市場擴張。

在本報告中，我們研究和分析了全球非甾體抗炎藥市場、市場動態、行業分析、COVID-19 的影響、按適應症、給藥途徑、分銷渠道、地區、公司簡介進行的市場分析等提供有關信息。

內容

第 1 章執行摘要

第 2 章全球非甾體抗炎藥市場定義和範圍

第三章全球非甾體抗炎藥:市場動態

• 非甾體抗炎藥市場影響分析（2020-2028）

第四章全球非甾體抗炎藥市場行業分析

• 波特五力模型
• PEST 分析
• 招商引資模式
• 分析師的建議和結論
• 主要投資機會
• 主要製勝策略

第 5 章風險評估:COVID-19 的影響

• 評估 COVID-19 對行業的整體影響
• COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球非甾體抗炎藥市場:按適應症分類

• 市場快照
• 全球非甾體抗炎藥市場:按適應症、性能 - 潛力分析
• 全球非甾體抗炎藥市場估計與預測:按適應症分類（2018-2028 年（十億美元））
• 非甾體抗炎藥市場:細分分析
  • 關節炎
  • 偏頭痛
  • 眼科疾病
  • 其他

第 7 章全球非甾體抗炎藥市場:按給藥途徑

• 市場快照
• 全球非甾體抗炎藥市場:按給藥途徑、性能 - 潛力分析
• 全球非甾體抗炎藥市場的估計和預測:按給藥途徑（2018-2028 年（十億美元））
• 非甾體抗炎藥市場:細分分析
  • 口語
  • 外用
  • 其他

第 8 章全球非甾體抗炎藥市場:按分銷渠道

• 市場快照
• 全球非甾體抗炎藥市場:按分銷渠道、業績 - 潛力分析
• 全球非甾體抗炎藥市場估計與預測:按分銷渠道（2018-2028 年（十億美元））
• 非甾體抗炎藥市場:細分分析
  • 醫院藥房
  • 零售藥房
  • 在線藥店

第 9 章全球非甾體抗炎藥市場:區域分析

• 區域市場概況
• 北美
  • 美國
  • 加拿大
• 歐洲快照
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 其他歐洲
• 亞太地區概況
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 其他亞太地區
• 拉丁美洲快照
  • 巴西
  • 墨西哥
• 世界其他地區

第 10 章衝突信息

• 主要市場策略
• 公司簡介
  • Pfizer Inc.
  • Bayer AG
  • GSK plc
  • Dr. Reddy's Laboratories Ltd
  • Viatris Inc
  • Teva Pharmaceutical Industries Ltd.
  • Johnson And Johnson Services, Inc.
  • Merck & Co., Inc.
  • Becton Dickinson & Company
  • Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)

第11章 調查流程

Global Non-steroidal Anti-inflammatory Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Nonsteroidal anti-inflammatory medications are members of a therapeutic medicine class that lowers pain, inflammation, fever, and blood clots. The market for nonsteroidal anti-inflammatory medications (NSAIDs) is expanding due to reasons such as the increased prevalence of chronic pain throughout the world, as well as an increase in the worldwide geriatric population. Furthermore, rising demand for OTC NSAIDs and increased use of NSAIDs in headaches, migraines, toothaches, and menstrual pain are likely to drive growth throughout the projection period. The increased prevalence of chronic pain is likely to drive NSAID market growth throughout the forecast period. According to the CDC, around 20.4 percent of the adult population in the United States suffered from chronic pain in 2019. Chronic pain became more common with age, peaking in those aged 65 and more. Furthermore, the rising prevalence of arthritis and other pain-related conditions is likely to drive market expansion throughout the forecast period. According to the CDC, approximately one in every four individuals in the United States, or around 58.5 million people, has arthritis. This arthritis is more frequent in women (23.5 percent) than in males (18.1 percent ). As a result, the increased prevalence of arthritis is predicted to contribute to growth throughout the projection period. CVDs, cancer, diabetes, chronic pain, arthritis, and other illnesses are more common in the elderly population. Thus, , the growing elderly population throughout the world is likely to drive market growth. According to an Administration on Aging (AoA) study, the population aged 65 and over in the United States was roughly 54.1 million in 2019, accounting for more than 16 percent of the total population. There were around 30 million women and approximately 24.1 million males among them. By 2040, this group is predicted to account for 21.6 percent of the total in the United States. As a result, the ongoing increase in the senior population is likely to fuel growth during the predicted period. However, side effects of the drugs impede market expansion throughout the projection period of 2022-2028.

The key regions considered for the Global Non-steroidal Anti-inflammatory Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America emerged as the market leader. Some of the primary reasons driving the industry's growth are the existence of a large number of manufacturers and strategic efforts implemented by market participants. Furthermore, the rising prevalence of chronic pain and arthritis is expected to drive growth throughout the projected period. During the projection period, Asia-Pacific is predicted to be the fastest-growing region. The area's rise is ascribed to causes such as an ageing population, an increase in the prevalence of chronic pain, migraines, and headaches, as well as an increase in product approvals and launches in the region.

Major market players included in this report are:

Pfizer Inc.

Bayer AG

GSK plc

Dr. Reddy's Laboratories Ltd

Viatris Inc

Teva Pharmaceutical Industries Ltd.

Johnson And Johnson Services, Inc.

Merck & Co., Inc.

Becton Dickinson & Company

Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Indication:

Arthritis

Migraine

Ophthalmic Diseases

Others

By Route of Administration:

Oral

Topical

Others

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Non-steroidal Anti-inflammatory Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
  • 1.2.1. Non-steroidal Anti-inflammatory Drugs Market, by Region, 2020-2028 (USD Billion)
  • 1.2.2. Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication, 2020-2028 (USD Billion)
  • 1.2.3. Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration, 2020-2028
  • 1.2.4. Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel, 2020-2028 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Non-steroidal Anti-inflammatory Drugs Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Non-steroidal Anti-inflammatory Drugs Market Dynamics

• 3.1. Non-steroidal Anti-inflammatory Drugs Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising prevalence of chronic pain across the globe
    • 3.1.1.2. Increasing demand for OTC NSAIDs and the rising adoption of NSAIDs
  • 3.1.2. Market Challenges
    • 3.1.2.1. Side effects of the drugs
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Technological improvements in Non-steroidal Anti-inflammatory Drugs

Chapter 4. Global Non-steroidal Anti-inflammatory Drugs Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication

• 6.1. Market Snapshot
• 6.2. Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, Performance - Potential Analysis
• 6.3. Global Non-steroidal Anti-inflammatory Drugs Market Estimates & Forecasts by Disease Indication 2018-2028 (USD Billion)
• 6.4. Non-steroidal Anti-inflammatory Drugs Market, Sub Segment Analysis
  • 6.4.1. Arthritis
  • 6.4.2. Migraine
  • 6.4.3. Ophthalmic Diseases
  • 6.4.4. Others

Chapter 7. Global Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration

• 7.1. Market Snapshot
• 7.2. Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, Performance - Potential Analysis
• 7.3. Global Non-steroidal Anti-inflammatory Drugs Market Estimates & Forecasts by Route of Administration 2018-2028 (USD Billion)
• 7.4. Non-steroidal Anti-inflammatory Drugs Market, Sub Segment Analysis
  • 7.4.1. Oral
  • 7.4.2. Topical
  • 7.4.3. Others

Chapter 8. Global Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel

• 8.1. Market Snapshot
• 8.2. Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, Performance - Potential Analysis
• 8.3. Global Non-steroidal Anti-inflammatory Drugs Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Billion)
• 8.4. Non-steroidal Anti-inflammatory Drugs Market, Sub Segment Analysis
  • 8.4.1. Hospital Pharmacy
  • 8.4.2. Retail Pharmacy
  • 8.4.3. Online Pharmacy

Chapter 9. Global Non-steroidal Anti-inflammatory Drugs Market, Regional Analysis

• 9.1. Non-steroidal Anti-inflammatory Drugs Market, Regional Market Snapshot
• 9.2. North America Non-Steroidal Anti-inflammatory Drugs Market
  • 9.2.1. U.S. Non-steroidal Anti-inflammatory Drugs Market
    • 9.2.1.1. Disease Indication breakdown estimates & forecasts, 2018-2028
    • 9.2.1.2. Route of Administration breakdown estimates & forecasts, 2018-2028
    • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2018-2028
  • 9.2.2. Canada Non-steroidal Anti-inflammatory Drugs Market
• 9.3. Europe Non-steroidal Anti-inflammatory Drugs Market Snapshot
  • 9.3.1. U.K. Non-steroidal Anti-inflammatory Drugs Market
  • 9.3.2. Germany Non-steroidal Anti-inflammatory Drugs Market
  • 9.3.3. France Non-steroidal Anti-inflammatory Drugs Market
  • 9.3.4. Spain Non-steroidal Anti-inflammatory Drugs Market
  • 9.3.5. Italy Non-steroidal Anti-inflammatory Drugs Market
  • 9.3.6. Rest of Europe Non-steroidal Anti-inflammatory Drugs Market
• 9.4. Asia-Pacific Non-steroidal Anti-inflammatory Drugs Market Snapshot
  • 9.4.1. China Non-steroidal Anti-inflammatory Drugs Market
  • 9.4.2. India Non-steroidal Anti-inflammatory Drugs Market
  • 9.4.3. Japan Non-steroidal Anti-inflammatory Drugs Market
  • 9.4.4. Australia Non-steroidal Anti-inflammatory Drugs Market
  • 9.4.5. South Korea Non-steroidal Anti-inflammatory Drugs Market
  • 9.4.6. Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market
• 9.5. Latin America Non-steroidal Anti-inflammatory Drugs Market Snapshot
  • 9.5.1. Brazil Non-steroidal Anti-inflammatory Drugs Market
  • 9.5.2. Mexico Non-steroidal Anti-inflammatory Drugs Market
• 9.6. Rest of The World Non-steroidal Anti-inflammatory Drugs Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Pfizer Inc.
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Disease Indication Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Bayer AG
  • 10.2.3. GSK plc
  • 10.2.4. Dr. Reddy's Laboratories Ltd
  • 10.2.5. Viatris Inc
  • 10.2.6. Teva Pharmaceutical Industries Ltd.
  • 10.2.7. Johnson And Johnson Services, Inc.
  • 10.2.8. Merck & Co., Inc.
  • 10.2.9. Becton Dickinson & Company
  • 10.2.10. Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Non-steroidal Anti-inflammatory Drugs Market, report scope
• TABLE 2. Global Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by Region 2018-2028 (USD Billion)
• TABLE 3. Global Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by Disease Indication 2018-2028 (USD Billion)
• TABLE 4. Global Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by Route of Administration 2018-2028 (USD Billion)
• TABLE 5. Global Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by Distribution Channel 2018-2028 (USD Billion)
• TABLE 6. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 7. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 8. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 9. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 10. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 11. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 12. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 13. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 14. Global Non-steroidal Anti-inflammatory Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 15. Global Non-steroidal Anti-inflammatory Drugs Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 16. U.S. Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 17. U.S. Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 18. U.S. Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 19. Canada Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 20. Canada Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 21. Canada Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 22. UK Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 23. UK Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 24. UK Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 25. Germany Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 26. Germany Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 27. Germany Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 28. RoE Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 29. RoE Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 30. RoE Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 31. China Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 32. China Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 33. China Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 34. India Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 35. India Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 36. India Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 37. Japan Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 38. Japan Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 39. Japan Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 40. RoAPAC Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 41. RoAPAC Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 42. RoAPAC Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 43. Brazil Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 44. Brazil Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 45. Brazil Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 46. Mexico Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 47. Mexico Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 48. Mexico Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 49. RoLA Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 50. RoLA Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 51. RoLA Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 52. Row Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 53. Row Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 54. Row Non-steroidal Anti-inflammatory Drugs Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 55. List of secondary sources, used in the study of global Non-steroidal Anti-inflammatory Drugs Market
• TABLE 56. List of primary sources, used in the study of global Non-steroidal Anti-inflammatory Drugs Market
• TABLE 57. Years considered for the study
• TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global Non-steroidal Anti-inflammatory Drugs Market, research methodology
• FIG 2. Global Non-steroidal Anti-inflammatory Drugs Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Non-steroidal Anti-inflammatory Drugs Market, key trends 2021
• FIG 5. Global Non-steroidal Anti-inflammatory Drugs Market, growth prospects 2022-2028
• FIG 6. Global Non-steroidal Anti-inflammatory Drugs Market, porters 5 force model
• FIG 7. Global Non-steroidal Anti-inflammatory Drugs Market, pest analysis
• FIG 8. Global Non-steroidal Anti-inflammatory Drugs Market, value chain analysis
• FIG 9. Global Non-steroidal Anti-inflammatory Drugs Market by segment, 2018 & 2028 (USD Billion)
• FIG 10. Global Non-steroidal Anti-inflammatory Drugs Market by segment, 2018 & 2028 (USD Billion)
• FIG 11. Global Non-steroidal Anti-inflammatory Drugs Market by segment, 2018 & 2028 (USD Billion)
• FIG 12. Global Non-steroidal Anti-inflammatory Drugs Market by segment, 2018 & 2028 (USD Billion)
• FIG 13. Global Non-steroidal Anti-inflammatory Drugs Market by segment, 2018 & 2028 (USD Billion)
• FIG 14. Global Non-steroidal Anti-inflammatory Drugs Market, regional snapshot 2018 & 2028
• FIG 15. North America Non-steroidal Anti-inflammatory Drugs Market 2018 & 2028 (USD Billion)
• FIG 16. Europe Non-steroidal Anti-inflammatory Drugs Market 2018 & 2028 (USD Billion)
• FIG 17. Asia pacific Non-steroidal Anti-inflammatory Drugs Market 2018 & 2028 (USD Billion)
• FIG 18. Latin America Non-steroidal Anti-inflammatory Drugs Market 2018 & 2028 (USD Billion)
• FIG 19. Global Non-steroidal Anti-inflammatory Drugs Market, company Market share analysis (2021)